A survey of biotech investors found that 86% believe that fewer than half of management teams communicate effectively, ...
CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...
CRISPR Therapeutics (CRSP) just announced that its SyNTase gene editing technology will be featured in an oral presentation at the ESGCT 2025 Congress. This marks the first major public unveiling of ...
The Brighterside of News on MSN
AI-powered CRISPR technology turbocharges gene therapy development
Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...
CRISPR-Cas systems are adaptive immune systems found in prokaryotes that defend against invading nucleic acids through CRISPR ...
As CRISPR continues to drive breakthroughs in medicine, agriculture, and synthetic biology, understanding its origins does more than tell an ancient story. It provides a blueprint for engineering the ...
The share of U.S. startup investment going to biotech companies has hit the lowest level in more than 20 years, as an ever-growing proportion of funding goes to AI upstarts in other sectors. We take a ...
The shift brings GSK into what Walmsley described as a “pivotal year.” Walmsley, a former executive from L’Oreal, shifted to ...
CRISPR Therapeutics (CRSP) announced the acceptance of an abstract for oral presentation at the European Society of Gene and Cell Therapy, ESGCT, ...
Phosphoproteomic profiling of Osimertinib drug-tolerant persister (DTP) cells identified dynamic signaling transitions and ...
Research reveals an increase in global filings in 2024/2025, but concerns remain over the future of vaccine development in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback